Going Viral

Earning CPD by listening to Healthed podcasts is simple. Each episode is eligible for Educational Activities CPD.

Filter results

0.5 EA, 0.5 RP

What’s happening in China now? Multiresistant mycoplasma infection may be the issue, ad the latest on new COVID vaccines arriving next week and in the next few months

0.5 EA, 0.5 RP

The current COVID wave, the latest news on vaccines and antivirals, and long COVID guidelines.

0.5 EA, 0.5 RP

COVID is still very much around, and older people are still most at risk of significant morbidity. We discuss management strategies, both in the community and in facilities, that can be beneficial in mitigating this risk.

0.5 EA, 0.5 RP

Basic statistics, epidemiology, and important events, and new variants and subvariants

0.5 EA, 0.5 RP

New variants (Eris, Pirola) and ATAGI guidelines

0.5 EA, 0.5 RP

Molnupiravir is still effective and protecting your most vulnerable patients

0.5 EA, 0.5 RP

Vaccine-related injury, long COVID, more on boosters.

0.5 EA, 0.5 RP

The current COVID situation- protect your vulnerable patients.

0.5 EA, 0.5 RP

WHO vs ATAGI booster advice, which do we use? Antivirals - positive evidence for Molnupiravir emerges.

0.5 EA, 0.5 RP

The WHO says the emergency is over - should we believe them? 2nd generation vaccines are needed- vaccine related injury.

0.5 EA, 0.5 RP

How do we tell the public it is not over? Are mask beneficial? How to justify the use of vaccines that can cause serious adverse reactions in healthy people.

0.5 EA, 0.5 RP

Which booster when? Is bivalent or monovalent better? Plus when non-mRNA boosters are appropriate

What’s happening in China now? Multiresistant mycoplasma infection may be the issue, ad the latest on new COVID vaccines arriving next week and in the next few months

The current COVID wave, the latest news on vaccines and antivirals, and long COVID guidelines.

COVID is still very much around, and older people are still most at risk of significant morbidity. We discuss management strategies, both in the community and in facilities, that can be beneficial in mitigating this risk.

Basic statistics, epidemiology, and important events, and new variants and subvariants

New variants (Eris, Pirola) and ATAGI guidelines

Molnupiravir is still effective and protecting your most vulnerable patients

Vaccine-related injury, long COVID, more on boosters.

The current COVID situation- protect your vulnerable patients.

WHO vs ATAGI booster advice, which do we use? Antivirals - positive evidence for Molnupiravir emerges.

The WHO says the emergency is over - should we believe them? 2nd generation vaccines are needed- vaccine related injury.

How do we tell the public it is not over? Are mask beneficial? How to justify the use of vaccines that can cause serious adverse reactions in healthy people.

Which booster when? Is bivalent or monovalent better? Plus when non-mRNA boosters are appropriate

Upcoming Healthed Webcast

Tune in for "Facial rashes case studies - Practical guide to assessment and management" lecture

Tuesday 9th June, 7pm - 9pm AEST

Speaker

Dr Philip Tong

Consultant Dermatologist; Founder, DermScreen, Dermatology Junction; Visiting Medical Officer, St Vincent’s Hospital Sydney

What does it mean when a facial red rash does not respond to topical steroids and gets worse with the treatment? Dermatologist Dr Philip Tong presents a series of cases with this scenario.